Skip to main content
Year archive

ACTINOGEN MEDICAL LIMITED — 2014 filings

All 50 regulatory filings released by ACTINOGEN MEDICAL LIMITED (ACW) in 2014, sourced directly from the official regulator.

50 Filings
2014 Period
2014 filings (50)
Filing Released Lang
Actinogen Board Changes 1 page 93.2KB
Board/Management Information
2014-12-17 English
Appendix 3X-Dr Bill Ketelbey 2 pages 72.6KB
Director's Dealing
2014-12-17 English
Final Director's Interest Notice 2 pages 20.2KB
Director's Dealing
2014-12-17 English
Actinogen Medical Appoints Dr Bill Ketelbey as CEO 3 pages 137.0KB
Board/Management Information
2014-12-14 English
Appendix 3B 12 pages 151.2KB
Capital/Financing Update
2014-12-14 English
Section 708A Notice 1 page 32.4KB
Share Issue/Capital Change
2014-12-14 English
Section 708A Notice 1 page 32.3KB
Share Issue/Capital Change
2014-12-07 English
Becoming a substantial holder 2 pages 112.4KB
Major Shareholding Notification
2014-12-07 English
Details of Company Address 1 page 104.9KB
Regulatory Filings
2014-12-07 English
Becoming a substantial holder 2 pages 43.3KB
Major Shareholding Notification
2014-12-04 English
Becoming a substantial holder 2 pages 63.1KB
Regulatory Filings
2014-12-04 English
Final Director's Interest Notice 2 pages 20.0KB
Director's Dealing
2014-12-03 English
Appendix 3X-Mr Martin Rogers 2 pages 72.1KB
Director's Dealing
2014-12-03 English
Appendix 3Y-Dr Anton Uvarov 2 pages 25.4KB
Director's Dealing
2014-12-03 English
Appendix 3X-Dr Jason Loveridge 2 pages 71.9KB
Director's Dealing
2014-12-03 English
Appendix 3Y-Dr Brendan de Kauwe 2 pages 25.5KB
Director's Dealing
2014-12-03 English
AusBiotech Invest Presentation 2014 11 pages 955.1KB
Investor Presentation
2014-12-02 English
Appendix 3B 12 pages 152.5KB
Capital/Financing Update
2014-12-02 English
Section 708A Notice 1 page 32.5KB
Capital/Financing Update
2014-12-01 English
R&D Tax Rebate Received 1 page 71.9KB
Capital/Financing Update
2014-11-30 English
Actinogen Completes Acquisition of Corticrine Limited 14 pages 202.2KB
Capital/Financing Update
2014-11-30 English
Results of Annual General Meeting 4 pages 67.8KB
Declaration of Voting Results & Voting Rights Announcements
2014-11-18 English
New Patents Allowed for B-HSD1 Inhibitor 2 pages 117.4KB
Regulatory Filings
2014-11-04 English
Appendix 4C & Commentary 10 pages 195.5KB
Interim / Quarterly Report
2014-10-22 English
Notice of Annual General Meeting/Proxy Form 82 pages 967.1KB
AGM Information
2014-10-15 English
Annual Report to shareholders 68 pages 1.3MB
Annual Report
2014-10-15 English
Appointment of Vice President of Clinical Research 1
Board/Management Information
2014-09-11 English
Change in Substantial Shareholding x 3 6 pages 2.2MB
Regulatory Filings
2014-09-02 English
Appendix 3B -Share Placement 12 pages 150.8KB
Capital/Financing Update
2014-09-01 English
Section 708A Notice 1 page 32.2KB
Capital/Financing Update
2014-09-01 English
Information Required under Asx Listing Rule 3.10.5A 1
Capital/Financing Update
2014-09-01 English
Actinogen to acquire Corticrine Limited 4 pages 176.9KB
Capital/Financing Update
2014-08-26 English
Capital Raising 1 page 56.5KB
Capital/Financing Update
2014-08-26 English
Proposed Board Changes 3 pages 69.7KB
Board/Management Information
2014-08-26 English
Appointment of Clinical Advisers 2 pages 89.9KB
Board/Management Information
2014-08-26 English
Investor Presentation 19 pages 1.4MB
Investor Presentation
2014-08-26 English
Trading Halt 2 pages 110.3KB
Capital/Financing Update
2014-08-25 English
Appendix 4E & Financial Statements 70 pages 1.3MB
Annual Report
2014-07-31 English
Appendix 4C & Commentary 9 pages 145.6KB
Interim / Quarterly Report
2014-07-30 English
Actinogen Isolates Demonstrate Antitumorigenic Activity 2 pages 46.1KB
Regulatory Filings
2014-06-12 English
Dr Brendan de Kauwe Appointed Executive Chairman 1
Board/Management Information
2014-04-22 English
Replacement Securities Trading Policy 10 pages 124.8KB
Governance Information
2014-04-22 English
Appendix 4C & Commentary 9 pages 135.6KB
Interim / Quarterly Report
2014-04-15 English
Appendix 3B - Exercise of Unlisted Options 12 pages 140.7KB
Share Issue/Capital Change
2014-04-09 English
Section 708A Notice 1 page 31.0KB
Share Issue/Capital Change
2014-04-09 English
Investor Presentation 17 pages 599.3KB
Investor Presentation
2014-03-17 English
Actinogen & Curtin Uni to Work on Cancer Stem Cells 2 pages 37.8KB
Regulatory Filings
2014-02-26 English
Appendix 4D & Half-Year Financial Statements 24 pages 524.0KB
Interim / Quarterly Report
2014-02-26 English
TRIALS RECOMMENCE ON ANTIBIOTIC PROJECT 2 pages 114.3KB
Regulatory Filings
2014-02-11 English
Appendix 4C & Commentary 8 pages 111.5KB
Interim / Quarterly Report
2014-01-22 English